Commentary Open Access
Volume 6 | Issue 6 | DOI: https://doi.org/10.33696/immunology.6.215
Risk of Venous Thrombotic Events in Systemic Lupus Erythematosus Patients: Genetic Insights
Maria I. Zervou1, George N. Goulielmos1,2,*
- 1Section of Molecular Pathology and Human Genetics, Department of Internal Medicine, School of Medicine, University of Crete, Heraklion, Greece
- 2Department of Internal Medicine, University Hospital of Heraklion, Heraklion, Greece
Corresponding Author
George N. Goulielmos, goulielmos@med.uoc.gr
Received Date: November 07, 2024
Accepted Date: December 31, 2024
Zervou MI, Goulielmos GN. Risk of Venous Thrombotic Events in Systemic Lupus Erythematosus Patients: Genetic Insights. J Cell Immunol. 2024;6(6):282-286.
Copyright: © 2024 Zervou MI, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
CD146-Positive Tumors are Associated with Venous Thromboembolism
The role of CD146 and its soluble form have been intensely reviewed in the processes of cancer and inflammation. However, how CD146 is linked to coagulation and thrombotic events remains unclear. The aim of this paper is to shed light on this topic and clarify the contribution of CD146 as a procoagulant factor.
Transient Right Bundle Branch Block with S1Q3T3 Pattern in Pulmonary Embolism
A 69-year-old woman with hypertension, hyperlipidemia, sleep apnea, gastroesophageal reflux disease, and recent knee replacement was brought to the emergency room (ER) for syncope. She had her physiotherapy session earlier in the day and became symptomatic with dizziness, shortness of breath and had loss of consciousness.